Novartis

Rwanda becomes third country to launch Novartis Access portfolio against chronic diseases with first deliveries planned in early 2017 Since September 2015, Novartis Access has delivered more than 100,000 monthly treatments to Kenya, Ethiopia and Lebanon* First-year learnings underline broader … Read the full press release →

LIVERPOOL, 25-Nov-2016 — /EuropaWire/ — A highly successful University scheme to train “high flyers” who are likely to become future leaders in academia and industry has been renewed by the Medical Research Council (MRC). The North West England MRC Clinical Research … Read the full press release →

Alcon to host first live training program on the use of the CyPass® Micro-Stent, a minimally invasive glaucoma surgical device to treat cataract patients with mild to moderate primary open-angle glaucoma Two-year safety and efficacy data from landmark COMPASS study … Read the full press release →

Despite significant advances made by modern medicine, universal access to healthcare is still arguably the single largest unmet medical need Sandoz “HACk” – Healthcare Access Challenge – is a competition seeking young people with innovative ideas to “reimagine” access to … Read the full press release →

LONDON, 29-Sep-2016 — /EuropaWire/ — GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately. He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty as … Read the full press release →

Ultibro® Breezhaler® reduced rate of all COPD exacerbations across different patient sub-groups vs Seretide® in new analyses from FLAME study Analyses show that Ultibro Breezhaler lowered patients’ need for rescue medication and had improved benefit-risk profile compared to Seretide, with … Read the full press release →

LONDON, 09-Aug-2016 — /EuropaWire/ — Scientists have identified a compound that can kill the parasites responsible for three neglected diseases: Chagas disease, leishmaniasis and sleeping sickness. These diseases affect millions of people in Latin America, Asia and Africa, but there are … Read the full press release →

The EGALITY study met its primary endpoint demonstrating equivalent efficacy of Sandoz biosimilar etanercept candidate to the originator product at week 12 As a first-of-its kind, the confirmatory clinical safety and efficacy study compares originator etanercept to a biosimilar candidate … Read the full press release →

Outlines actions underway to accelerate launch of Entresto®, including further expansion of US primary care field force, and reinforce strong uptake of Cosentyx® Highlights leading pipeline of second generation immuno-oncology assets Confirms Sandoz on track for 10 biosimilar filings by … Read the full press release →

Sandoz advances biosimilar portfolio with sixth major biosimilar file acceptance in less than one year Sandoz is seeking approval for all indications included in the reference product’s label Sandoz’ submission includes data from multiple clinical trials with over 800 patients … Read the full press release →

EU approval of Revolade expands treatment options for pediatric patients aged 1 year and above with chronic ITP who have not responded to other therapies Two formulations approved: once-daily tablet and oral suspension formulation designed for younger children who may … Read the full press release →

BERN, 06-Apr-2016 — /EuropaWire/ — Great progress has been made in the fight against malaria – since 2000, malaria incidence among populations at risk (the rate of new cases) fell by 37% globally – yet there is so much more to … Read the full press release →

Dundee, Scotland, 30-Mar-2016 — /EuropaWire/ — Professor Doreen Cantrell, Wellcome Trust Principal Research Fellow and Dean of the School of Life Sciences at the University of Dundee, is to be awarded one of the UK’s most prestigious honours in biochemistry, the … Read the full press release →

AMSTERDAM, 11-Feb-2016 — /EuropaWire/ — Andrew Stevens, a research director on the Gartner Core Supply Chain team, will be one of the keynote speakers at Systech International’s upcoming global conference, UNIQUITY Europe, 2016, on serialization, global brand protection and consumer … Read the full press release →

2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease Last … Read the full press release →